U.S. Markets open in 5 hrs 14 mins

Genesee & Wyoming Unveils Impressive October Traffic Data

Zacks Equity Research
1 / 2

Genesee & Wyoming Unveils Impressive October Traffic Data

Impressive performance at Genesee & Wyoming's (GWR) North American unit drives its October traffic.

Genesee & Wyoming, Inc. GWR reported increase traffic volumes for October. Traffic in the month was 286,180 carloads, reflecting a 3.9% increase year over year. The railroad’s same railroad traffic (excluding carloads from the Continental European intermodal business sold in June 2018) climbed 7.1%.

Segmental Traffic

Traffic in the company’s North American operations expanded 8.1% from the year-ago figure owing to impressive growth across most of its commodity groups. Notably, the intermodal segment was the most impressive performer, with its traffic rising 77%. On the flip side, the autos & auto parts group performed disappointingly, with traffic declining 41.2% due to  decreased shipments in the western and midwest regions.

Australian operations (owned 51.1% by the company) traffic improved 15.1%, courtesy of   43.5% and 24.7% traffic growth at the metallic ores and coal & coke groups, respectively. Meanwhile, traffic at the agricultural products and petroleum products group plunged 83.9% and 13.8%, respectively.

Total traffic at U.K./European operations declined 7% from the last October-level, mainly due to a 13.1% decrease in the segment’s intermodal traffic.

Genesee & Wyoming, Inc. Price

Genesee & Wyoming, Inc. Price | Genesee & Wyoming, Inc. Quote

 

Zacks Rank & Key Picks

Genesee & Wyoming carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader Transportation sector are Air France-KLM SA AFLYY, CSX Corporation CSX and Spirit Airlines, Inc. SAVE, each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Shares of Air France-KLM have rallied more than 28% in the past six months, while CSX and Spirit Airlines have gained more than 44% and 43%, respectively, in a year.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Spirit Airlines, Inc. (SAVE) : Free Stock Analysis Report
 
Air France-KLM SA (AFLYY) : Free Stock Analysis Report
 
CSX Corporation (CSX) : Free Stock Analysis Report
 
Genesee & Wyoming, Inc. (GWR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.